177 related articles for article (PubMed ID: 15480048)
21. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
[TBL] [Abstract][Full Text] [Related]
22. Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination.
Rangaswamy B; Fardanesh MR; Genden EM; Park EE; Fatterpekar G; Patel Z; Kim J; Som PM; Kostakoglu L
Laryngoscope; 2013 Nov; 123(11):2664-9. PubMed ID: 23553147
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Fischbein NJ; AAssar OS; Caputo GR; Kaplan MJ; Singer MI; Price DC; Dillon WP; Hawkins RA
AJNR Am J Neuroradiol; 1998 Aug; 19(7):1189-96. PubMed ID: 9726451
[TBL] [Abstract][Full Text] [Related]
24. Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer.
Gourin CG; Watts T; Williams HT; Patel VS; Bilodeau PA; Coleman TA
Laryngoscope; 2009 Apr; 119(4):703-6. PubMed ID: 19205017
[TBL] [Abstract][Full Text] [Related]
25. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
Farber LA; Benard F; Machtay M; Smith RJ; Weber RS; Weinstein GS; Chalian AA; Alavi A; Rosenthal DI
Laryngoscope; 1999 Jun; 109(6):970-5. PubMed ID: 10369292
[TBL] [Abstract][Full Text] [Related]
26. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.
Chang JT; Chan SC; Yen TC; Liao CT; Lin CY; Lin KJ; Chen IH; Wang HM; Chang YC; Chen TM; Kang CJ; Ng SH
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):501-7. PubMed ID: 15890593
[TBL] [Abstract][Full Text] [Related]
27. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
Kubota K; Yokoyama J; Yamaguchi K; Ono S; Qureshy A; Itoh M; Fukuda H
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):590-5. PubMed ID: 14722678
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography in the evaluation of stage III and IV head and neck cancer.
Teknos TN; Rosenthal EL; Lee D; Taylor R; Marn CS
Head Neck; 2001 Dec; 23(12):1056-60. PubMed ID: 11774391
[TBL] [Abstract][Full Text] [Related]
30. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
31. Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.
Senft A; Hoekstra OS; Witte BI; Leemans CR; de Bree R
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2643-50. PubMed ID: 26350882
[TBL] [Abstract][Full Text] [Related]
32. F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma.
Cetina L; Serrano A; Cantú-de-León D; Pérez-Montiel D; Estrada E; Coronel J; Hernández-Lucio M; Dueñas-González A
Rev Invest Clin; 2011; 63(3):227-35. PubMed ID: 21888286
[TBL] [Abstract][Full Text] [Related]
33. Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities.
Sigg MB; Steinert H; Grätz K; Hugenin P; Stoeckli S; Eyrich GK
J Oral Maxillofac Surg; 2003 Sep; 61(9):1022-9. PubMed ID: 12966477
[TBL] [Abstract][Full Text] [Related]
34. PET/CT for Head and Neck Squamous Cell Carcinoma: Should We Routinely Include the Head and Abdomen?
Yankevich U; Hughes MA; Rath TJ; Fakhran S; Alhilahi LM; Seungwon KW; Branstetter BF
AJR Am J Roentgenol; 2017 Apr; 208(4):844-848. PubMed ID: 28177644
[TBL] [Abstract][Full Text] [Related]
35. Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.
Uyl-de Groot CA; Senft A; de Bree R; Leemans CR; Hoekstra OS
J Nucl Med; 2010 Feb; 51(2):176-82. PubMed ID: 20124045
[TBL] [Abstract][Full Text] [Related]
36. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
37. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
Loo SW; Geropantas K; Beadsmoore C; Montgomery PQ; Martin WM; Roques TW
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):512-7. PubMed ID: 21501953
[TBL] [Abstract][Full Text] [Related]
38. Should We Routinely Investigate Incidental Head and Neck Findings on 18-Fluorodeoxyglucose Positron Emission Tomography in Patients Being Staged for Non-small Cell Lung Cancer? A Retrospective Analysis.
Patel A; Perry T; Hunt I; Abele J; Maquire C; Allegretto M; Bedard E
Thorac Cardiovasc Surg; 2015 Oct; 63(7):604-8. PubMed ID: 24959935
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
[TBL] [Abstract][Full Text] [Related]
40. Positron-emission tomography for surveillance of head and neck cancer.
Ryan WR; Fee WE; Le QT; Pinto HA
Laryngoscope; 2005 Apr; 115(4):645-50. PubMed ID: 15805874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
